cerrar
Tagged with IP

The UAE: A Gathering Force
Accounting for less than two percent of the global pharmaceutical market, the Middle East has long been somewhat overlooked by many drug makers, most…

Hot Topics in US Healthcare & Pharma
So far in 2020 PharmaBoardroom has conducted interviews with several key stakeholders in US healthcare. We have heard from leaders the US FDA, as well…

5 Cell & Gene Companies to Watch in South Korea
South Korea is the 12th largest healthcare market globally with a market size of around USD 20 billion in 2019. With the government’s plans to…

Jingsong Wang – Chairman & CEO, Harbour BioMed, China
PharmaBoardroom caught up with Dr Jingsong Wang, chairman & CEO of Harbour BioMed to discuss the exciting clinical and commercial milestones of…

Mauricio Guizar – General Manager, Ipsen Mexico
Mauricio Guizar, newly appointed general manager of Ipsen Mexico since October 2019, shares his first impression of the French specialty care…

Amalia Mihai – Market Access Manager, Ipsen Romania
Amalia Mihai, market access manager of Ipsen Romania explains that over the course of 26 years Ipsen has been increasingly helping Romanian patients…

Jorge Levinson – Head, Bayer Pharmaceuticals Romania &…
Jorge Levinson, head of Bayer Pharmaceuticals Romania and Moldova, reveals his first impressions of Romania and the untapped potential it offers to…

Indian Generics in the USA: Destined for More Success?
A recent IQVIA report highlights the increasing importance of Indian firms to the USA’s burgeoning generic pharmaceuticals market. Now…

A New Era of Access to Innovation in the Czech Republic?
Pharma industry stakeholders are generally quick to suggest that the Czech Republic is one of the most over-regulated markets in Europe, with new or…

Layla Laassel Sentissi – Executive Director, Moroccan…
Layla Sentissi, executive director of AMIP, Morocco’s oldest pharma association, explains the structure of the country’s pharmaceutical industry…

Patrik Zachar – Vice President Central Europe, Ipsen
Patrik Zachar, Vice President Central Europe of Ipsen, shares how the company has built a strong presence in oncology and neuroscience in the CE…

Alternative Models of Industry-Academia Research Collaboration in…
Hungary’s longstanding tradition of pharmacology is a major point of pride for the country’s scientists and researchers who today have hopes to…
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here